Management of blood pressure (BP) in the patients with chronic kidney disease (CKD) receiving dialysis (stage 5D)\nprovides a significant confront for healthcare professionals. The association between BP and cardiovascular disease risk has\nbeen well studied in the general population; however, in dialysis patients physiological and dialysis-related mechanisms\ninfluencing BP are complex and the associated risk is poorly understood. Hence present study was conducted to verify the\nprescribing patterns of antihypertensive in patients undergoing maintenance haemodialysis therapy and assess the factors that\nare influencing the outcome. A prospective cross sectional observational study was conducted in end stage renal disease (ESRD)\npatients undergoing maintenance haemodialysis in two nephrology wards of Varma Hospitals, Bhimavarm with study period of\nsix months. Morisky medication Adherence Scale (MMAS-8) was used to assess the medication adherence of patients to\nantihypertensive regimen. A total 104 patients were undergoing haemodialysis out of which 76 patients were undergoing\nmaintenance (at least 3 month on start of dialysis) were taken into consideration. Present study reveals that out of the 76\npatients in the study population 40 patients found to be pre-existing with hypertension. It shows that more than half the study\npopulation (52.63%) might have developed chronic kidney disease with hypertension as risk factor. Diabetes stands next to\nhypertension in the risk factors causing renal disease. 23 (30.26%) patients are pre-existing with diabetes. 11 (14.4%) patients\nare having the history of both diabetes and hypertension. Our study findings conclude that most of the patients undergoing\nhaemodialysis have their blood pressure uncontrolled; the major reason for this is lack of adherence to medication due to\npolypharmacy and increasing incidence of resistant hypertension.
Loading....